ARCHIVES

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

Funding Opportunities

December 6, 2002

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988

Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap

May 8, 1992

Budget Process for FY ’81 Starts; Investigators Initiated Definition May Be Heated Issues

August 31, 1979